| Primary |
| Asthma |
18.2% |
| Supplementation Therapy |
10.0% |
| Crohn's Disease |
8.2% |
| Colitis Ulcerative |
7.6% |
| Pancreatitis |
6.5% |
| Prophylaxis |
5.9% |
| Hypertension |
5.3% |
| Premedication |
4.7% |
| Acute Lymphocytic Leukaemia |
4.1% |
| Hypersensitivity |
4.1% |
| Adrenal Insufficiency |
3.5% |
| Dermatitis Atopic |
2.9% |
| Sedation |
2.9% |
| Allergy Prophylaxis |
2.4% |
| Anaphylactic Reaction |
2.4% |
| Bronchospasm |
2.4% |
| Nausea |
2.4% |
| Pain |
2.4% |
| Pneumonia |
2.4% |
| Alcohol Withdrawal Syndrome |
1.8% |
|
| Mania |
14.8% |
| Asthma |
13.1% |
| Shock |
6.6% |
| Sinus Bradycardia |
6.6% |
| Urticaria |
6.6% |
| Myopathy |
4.9% |
| Pneumonia |
4.9% |
| Cardiac Arrest |
3.3% |
| Cardiac Disorder |
3.3% |
| Diabetes Insipidus |
3.3% |
| Drug Ineffective |
3.3% |
| Dyspnoea |
3.3% |
| Food Poisoning |
3.3% |
| Loss Of Consciousness |
3.3% |
| Platelet Count Decreased |
3.3% |
| Pulmonary Oedema |
3.3% |
| Pyrexia |
3.3% |
| Respiratory Failure |
3.3% |
| Syncope |
3.3% |
| Tachycardia Foetal |
3.3% |
|
| Secondary |
| Hypertension |
10.8% |
| Supplementation Therapy |
9.3% |
| Acute Myeloid Leukaemia |
8.4% |
| Pain |
7.7% |
| Psoas Abscess |
7.2% |
| Electrolyte Substitution Therapy |
5.8% |
| Burkitt's Lymphoma |
5.0% |
| Drug Use For Unknown Indication |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Acute Lymphocytic Leukaemia |
4.9% |
| Hiv Infection |
4.1% |
| Stupor |
4.1% |
| Hyperglycaemia |
3.6% |
| Restlessness |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
| Arthritis |
3.0% |
| Polyuria |
2.6% |
| T-cell Type Acute Leukaemia |
2.6% |
| Hypothyroidism |
2.2% |
| Constipation |
2.1% |
|
| Stevens-johnson Syndrome |
13.3% |
| Urinoma |
12.0% |
| Pancreatitis Acute |
9.6% |
| Septic Shock |
7.2% |
| Toxic Epidermal Necrolysis |
7.2% |
| Sensorimotor Disorder |
6.0% |
| Food Poisoning |
4.8% |
| Mucosal Inflammation |
3.6% |
| Osteoporosis |
3.6% |
| Spinal Compression Fracture |
3.6% |
| Staphylococcal Sepsis |
3.6% |
| Thrombocytopenia |
3.6% |
| Ureteric Stenosis |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Cd4 Lymphocytes Decreased |
2.4% |
| Diabetes Insipidus |
2.4% |
| Faecal Incontinence |
2.4% |
| Febrile Neutropenia |
2.4% |
| Hypersensitivity |
2.4% |
| Hypomania |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.2% |
| Prophylaxis |
12.4% |
| Infection Prophylaxis |
8.3% |
| Drug Use For Unknown Indication |
4.7% |
| Aplastic Anaemia |
4.2% |
| Premedication |
4.1% |
| Bone Marrow Conditioning Regimen |
3.1% |
| Prophylaxis Against Graft Versus Host Disease |
2.9% |
| Constipation |
2.4% |
| Insomnia |
2.2% |
| Acute Myeloid Leukaemia |
2.0% |
| Antiviral Prophylaxis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Graft Versus Host Disease |
1.6% |
| Hypertension |
1.6% |
| Antifungal Prophylaxis |
1.3% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Acute Graft Versus Host Disease |
1.1% |
| Antibiotic Prophylaxis |
1.1% |
| Back Pain |
1.0% |
|
| White Blood Cell Count Decreased |
14.0% |
| Pyrexia |
12.5% |
| Staphylococcal Sepsis |
12.3% |
| Fungal Infection |
10.8% |
| Toothache |
6.6% |
| Vomiting |
6.3% |
| Sepsis |
4.0% |
| Stomatitis |
4.0% |
| Urticaria |
3.4% |
| Pneumonia |
3.1% |
| Insomnia |
2.8% |
| Ventricular Tachycardia |
2.8% |
| Graft Versus Host Disease In Skin |
2.6% |
| Renal Failure |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Thrombocytopenia |
2.3% |
| Venoocclusive Liver Disease |
2.3% |
| Enterococcal Infection |
1.7% |
| Pancreatitis Acute |
1.7% |
| Rash |
1.7% |
|
| Interacting |
| Pneumonia |
50.0% |
| Bronchospasm |
33.3% |
| Muscle Relaxant Therapy |
16.7% |
|
|
